Cognex Corporation (CGNX)
Information Technology · Industrial Automation & Machine Vision · NASDAQ
Cognex is a global leader in machine vision technology, providing AI-powered systems that enable industrial robots and factory automation equipment to 'see' and make decisions in complex manufacturing environments.
What Cognex Corporation does
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products that use artificial intelligence and sophisticated vision technology to perform inspection, guidance, identification, and gauging tasks. The company's products are used to automate manufacturing processes, improve quality, and increase production speed in various industries.
Themes: industrial automation, artificial intelligence / machine vision, factory of the future, robotics enablement, e-commerce logistics automation
Fundamentals
- Price$60.91 as of 2026-10-08 close
- Market cap$10.2B as of 2026-08-02 (share count; price 2026-10-08)
- 1-year return+30.3% 2025-10-08 close $46.75 → 2026-10-08 close $60.91
- P/E58.98 as of 2026-10-08
- Net margin+11.5% FY2025, SEC XBRL
- Gross margin+66.9% FY2025, SEC XBRL
- ROE+7.7% FY2025, SEC XBRL
- Debt / equity0.00 as of 2026-09-03
- Revenue growth (YoY)+17.1% as of 2026-09-03
- Revenue CAGR (3y)-0.4% SEC XBRL
- Beta1.43 as of 2026-09-03
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.6%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
How CGNX compares in its sector
- price-to-earnings ratiomiddle range 253 covered Information Technology peers, as of 2026-10-08
- net profit marginmiddle range 380 covered Information Technology peers, as of 2026-09-03
- operating margintop 25% 375 covered Information Technology peers, as of 2026-09-03
- gross marginmiddle range 311 covered Information Technology peers, as of 2026-09-03
- return on equitymiddle range 370 covered Information Technology peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 385 covered Information Technology peers
- indicated dividend yieldmiddle range 108 covered Information Technology peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)middle range 382 covered Information Technology peers, as of FY2025
Position among covered Information Technology companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CGNX is not currently in any published Top 10 list. Its scores are below.
Top 10 score
57.3 #340 of 1,379 scored · #61 of 203 in Information Technology
Financial health 88th (debt to equity 0, free cash flow margin 23.8%) and trend 71st (a "golden cross" — its 50-day average is above its 200-day); weakest is valuation (30th, price to book 6.3, price to earnings 59).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CGNX's dividend was covered by reported results (earnings payout 48%, free-cash-flow payout 23%). This describes past coverage, not a forecast.
- Earnings payout48% dividends / net income
- Free-cash-flow payout23% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Cognex Corporation looks technically
Cognex Corporation (CGNX) is trading 8.9% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 287 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 12, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive). It made a new 20-day high about 3 trading days ago. It is 16.4% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 8.9% above its 200-day average, the long-term trend line — a longer-term uptrend | +8.9% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $62.23 | $62.23 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $55.91 | $55.91 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 57.1. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 287 trading days ago — a "golden cross", a bullish long-term signal | 287 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 12, below the 25 that marks a real trend) | 12.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30) | 48.3 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($57.10 to $66.61) — its "stochastic" reading is 40 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 40.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $72.88 | $72.88 |
|---|---|---|
| From the 52-week high | it is 16.4% below its 52-week high (its highest price of the past year) | -16.4% |
| Above the 52-week low | it is 76.0% above its 52-week low (its lowest price of the past year) | +76.0% |
| Below the 52-week high | it is 16.4% below its highest point of the past year | 16.4% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day low about 11 trading days ago | 11 sessions |
| All-time high | its highest closing price on record is $101.82 (set on 2021-02-12) | $101.82 |
| Given back of the 52-week move | over the past year its closes ranged ($34.80 to $72.42), and it has given back roughly a third of its rise from last year’s low — 31% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $47.97 to $49.17. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 30.6% |
| From the all-time high | it is 40.2% below its all-time high | -40.2% |
| Nearest price level | it is trading 1.2% above a support level at $60.19 — a price it turned at three times since 2026-02-12, most recently on 2026-07-17. Since 2024-10-08 it has 15 such levels below the current price and 3 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.2% |
| All-time low | its lowest closing price on record is $2.37 (set on 2009-03-09) | $2.37 |
| Above the all-time low | it is 2475.5% above its all-time low | +2,475% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 42nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.39 between its high and its low — about 3.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.39 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $56.33 and $65.70 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $56.33 – $61.02 – $65.70 |
| Typical daily range (% of price) | its price moves about 3.9% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.9% |
| Stretch from the 200-day average | it is trading 2.1 daily ranges above its 200-day average price (8.9% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.1 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.14× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.3% since the prior reading | -0.3% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 1.2% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.2% |
|---|---|---|
| Open gap | it gapped 2.6% below the previous close 1 session ago and has not traded back through the level it left behind at 66.35 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -2.6% |
| Gap filled | a 2.3% gap up opened on 2026-09-22 has been "filled" 12 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 12 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -8.2% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 3.2 percentage points (the stock lost 2.1% while the market gained 1.0%) | -3.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 8.8 percentage points (the stock lost 5.0% while the market gained 3.8%) | -8.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 5.5 percentage points (the stock gained 23.0% while the market gained 17.5%) | +5.5% |
| vs market, 12 months | over the past 12 months this stock beat the market by 15.3 percentage points (the stock gained 30.3% while the market gained 15.0%) | +15.3% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 3.1% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 3.5% of the share price. | -3.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 5% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $58.06 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +4.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% below the average price paid since it last reported on 2026-08-05 (its 8-K), so the typical buyer over that stretch is under water. That average is $62.24 — a volume-weighted average of daily closes over 46 sessions, not a true tick-by-tick VWAP. | -2.1% |
Descending triangle, either side — broke out · entry $60.43 · 50 sessions in
Double bottom, bullish — broke out · entry $64.22 · 32 sessions in
Price levels it has turned at before
CGNX last closed at $60.91 on 2026-10-08. Since 2024-10-08 it has turned at 15 prices below its last close and 3 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $60.19 | Support | 1.2% below the last close | turned there three times · 2026-02-12 to 2026-07-17 |
| $63.00 | Resistance | 3.4% above the last close | turned there four times · 2026-06-24 to 2026-09-22 |
| $58.56 | Support | 3.9% below the last close | turned there four times · 2026-02-25 to 2026-09-03 |
| $57.18 | Support | 6.1% below the last close | turned there five times · 2026-04-14 to 2026-09-24 |
| $67.83 | Resistance | 11.3% above the last close | turned there twice · 2026-06-16 to 2026-08-17 |
| $72.49 | Resistance | 19.0% above the last close | turned there three times · 2026-05-07 to 2026-08-05 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $57.10.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 6 trading days, since 2026-10-01.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Broke out to a new 20-day high · trendless / choppy (low ADX) · beating the market · Under water since its last earnings report (below the anchored VWAP) · Trading below the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.85 mean, 1=Strong Buy…5=Strong Sell) — 19 analysts
- Mean price target$79.37 range $65.00 – $92.00; median $80.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CGNX
- Consensus EPS estimate$0.5183 next reporting period, as of 2026-10-07
- Estimate change, 30 days+$0.00176 (+0.3%) from $0.5166, on 2026-09-02, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Cyclicality of demand from capital-intensive industries such as automotive and consumer electronics.","Significant competition from both large diversified automation companies and specialized machine vision firms.","Reliance on a global supply chain and complex manufacturing operations."]
What changed in the latest 10-Q
AI-assisted comparison of CGNX's 10-Q filed 2026-08-06 against the prior one filed 2026-05-07.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-06) states that revenue for the second quarter of 2026 totaled $291,263,000, representing an increase of 17% over the second quarter of 2025 due to broad-based strength across most major end markets, as well as the favorable impact of foreign currency exchange rate changes on revenue.
- Newer filing (2026-08-06) states that gross margin as a percentage of revenue was 71% for the second quarter of 2026 compared to 67% for the second quarter of 2025 due to a more favorable end-market mix and higher sales volume, which improved fixed-cost absorption.
- Newer filing (2026-08-06) states that operating expenses for the second quarter of 2026 decreased 3% from the second quarter of 2025, primarily due to savings from continued cost management activities and lower stock-based compensation expense, partially offset by the unfavorable impact of foreign exchange rates on expenses.
- Newer filing (2026-08-06) refers to 'Ope' at the end of the provided excerpt, indicating additional MD&A content beyond the excerpt.
- Removed:
- Older filing (2026-05-07) stated that revenue for the first quarter of 2026 totaled $268,437,000, representing an increase of 24% over the first quarter of 2025 due to broad-based strength across our major end markets, as well as the favorable impact of foreign currency exchange rate changes on revenue.
- Older filing (2026-05-07) stated that gross margin as a percentage of revenue was 71% for the first quarter of 2026 compared to 67% for the first quarter of 2025 due to a more favorable end-market mix and increased cost efficiencies from higher sales volume.
- Older filing (2026-05-07) stated that operating expenses for the first quarter of 2026 increased 11% from the first quarter of 2025, with higher incentive compensation accruals, unfavorable foreign exchange impact, and higher reorganization charges partially offset by savings from continued cost management activities.
- Older filing (2026-05-07) stated that operating income increased to 22% of revenue for the first quarter of 2026 compared to 12% of revenue for the first quarter of 2025.
- Reworded:
- Newer filing (2026-08-06) changed the identity of the company from an unnamed 'the Company' in the older filing (2026-05-07) to 'Cognex Corporation ("Cognex", "we", "us", "our", or the "Company")' in the forward-looking statements paragraph.
- Newer filing (2026-08-06) changed risk factor (1) from 'the technological obsolescence of current products and the inability to develop new products' to 'the technological obsolescence of current products, the inability to develop new products, and the inability to achieve growth through expanding and adjacent markets.'
- Newer filing (2026-08-06) changed risk factor (8) from 'the inability to effectively scale our operations and salesforce to support a significantly expanded customer base' to 'the inability to effectively scale our operations and salesforce to support a significantly expanded customer base in an increasing number of geographies.'
- Newer filing (2026-08-06) changed risk factor (10) from 'data privacy, data protection, AI, or other automated technologies' to 'data privacy, data protection, artificial intelligence, or other automated technologies.'
- Newer filing (2026-08-06) changed the revenue discussion from first quarter 2026 figures to second quarter 2026 figures.
- Newer filing (2026-08-06) changed the gross margin explanation from 'increased cost efficiencies from higher sales volume' to 'higher sales volume, which improved fixed-cost absorption.'
- Newer filing (2026-08-06) changed the operating expenses discussion from an increase of 11% to a decrease of 3%, with different contributing factors.
- Notes:
- The newer filing excerpt is truncated and ends mid-sentence with 'Ope', so the full extent of the MD&A changes beyond that point cannot be assessed.
- The older filing excerpt is also truncated and ends mid-sentence with 'for the first', so its full MD&A content beyond that point is not available for comparison.
Risk Factors
- Added:
- Newer Item 5 discloses that on May 11, 2026, Matt Moschner, President and CEO, adopted a Rule 10b5-1 Trading Plan with a term ending August 10, 2027, providing for the exercise of vested stock options to sell up to 29,813 shares and the sale of 45,548 shares of common stock.
- Newer Item 5 discloses that on May 11, 2026, Sheila DiPalma, EVP of Employee Services, adopted a Rule 10b5-1 Trading Plan with a term ending December 31, 2026, providing for the exercise of vested stock options to sell up to 425,948 shares and the sale of 6,582 shares of common stock.
- Newer Item 5 discloses that on May 29, 2026, Laura MacDonald, VP and Principal Accounting Officer, adopted a Rule 10b5-1 Trading Plan with a term ending May 31, 2027, providing for the exercise of vested stock options to sell up to 59,556 shares and the sale of 5,258 shares of common stock.
- Newer Item 5 discloses that on June 9, 2026, Carl Gerst, EVP of Global Sales and Products, adopted a Rule 10b5-1 Trading Plan with a term ending April 1, 2027, providing for the exercise of vested stock options to sell up to 105,360 shares and the sale of 24,581 shares of common stock.
- Newer Item 5 states that during the quarter ended July 5, 2026, no 10b5-1 trading arrangements were modified or terminated, and no director or officer adopted or terminated a non-Rule 10b5-1 trading arrangement.
- Newer Item 6 includes Exhibit 3.1 (Second Amended and Restated By-laws of Cognex Corporation, effective February 19, 2025).
- Newer Item 6 includes Exhibit 10.1 (Amendment No. 1 to the Cognex Corporation 2023 Stock Option and Incentive Plan).
- Removed:
- Older Item 5 stated that during the quarter ended April 5, 2026, none of the Company's directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.
- Reworded:
- Item 2 table in the newer filing covers the three-month period ended July 5, 2026, while the older filing covered the three-month period ended April 5, 2026.
- Item 2 footnote (1) in the newer filing says 'the Board authorized a program providing for the repurchase of up to $500,000,000' while the older filing says 'the Company's Board of Directors authorized a program providing for the repurchase of $500,000,000'.
- Item 2 footnote (1) in the newer filing says 'On February 11, 2026, the Board authorized the repurchase of up to an additional $ 500,000,000' while the older filing says 'On February 11, 2026, the Board authorized the repurchase of an additional $ 500,000,000'.
- The signature date in the newer filing is August 6, 2026, while the older filing signature date is May 7, 2026.
- Notes:
- Item 1A Risk Factors text itself is identical in both filings: both state there have been no material changes to the risk factors included in the Annual Report.
- This comparison includes adjacent items (Item 2 through signatures) because the provided section text contains them, but differences in those adjacent items should not be attributed to the Risk Factors section.
- The repurchase table figures differ between filings solely due to the different reporting periods, not a change in the Risk Factors disclosure.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 5 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 5 sells ($2M) — 1 selling insider
- Last 180 days · read to 2026-10-040 buys · 26 sells ($17M) — 4 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-11. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CGNX's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding CGNX as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 22,586,018
- Reported value $1,635,679,352
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CGNX's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CGNX had 7,132,531 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CGNX had 4.24% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.01 days to cover at the same settlement.
- Reported short interest (shares) 7,132,531
- Short interest (% of shares outstanding) 4.24%
- Prior settlement (shares) 7,696,027
- Reported change -7.32%
- Days to cover (reported) 5.01
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Keyence (KYCCF)
- Omron Corporation (OMRNY)
- Basler AG (BSLR)
- Sick AG
- Teledyne DALSA (TDY)
- National Instruments (NI)
- Zebra Technologies (ZBRA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CGNX vs…
Cognex Corporation is found in…
Frequently asked questions
What does Cognex Corporation (CGNX) do?
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products that use artificial intelligence and sophisticated vision technology to perform inspection, guidance, identification, and gauging tasks. The company's products are used to automate manufacturing processes, improve quality, and increase production speed in various industries.
What sector is Cognex Corporation (CGNX) in?
Cognex Corporation (CGNX) is classified in the Information Technology sector. Its industry is Industrial Automation & Machine Vision. It trades on NASDAQ.
Does CGNX pay a dividend?
Yes — Cognex Corporation (CGNX) pays a dividend, with an indicated yield of about 0.58% and 5-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Cognex Corporation's (CGNX) competitors?
Notable peers of Cognex Corporation (CGNX) include Keyence, Omron Corporation, Basler AG, Sick AG and Teledyne DALSA. This peer set is informational only — not financial advice.
Is Cognex Corporation (CGNX) overbought or oversold right now?
Cognex Corporation (CGNX) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 48, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CGNX come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.